Titre:
  • Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group.
Auteur:Bottomley, Andrew; Coens, Corneel; Suciu, Stefan; Santinami, M.; Kruit, Willem; Testori, Alessandro; Marsden, Jeremy; Punt, Cornelis; Sales, François; Gore, Martin; Mackie, Rona; Kusic, Zvonko; Dummer, Reinhard; Patel, Poulam; Schadendorf, Dirk; Spatz, Alain; Keilholz, Ulrich; Eggermont, A
Informations sur la publication:Journal of clinical oncology, 27, 18, page (2916-2923)
Statut de publication:Publié, 2009-06
Sujet CREF:Cancérologie
MeSH keywords:Chemotherapy, Adjuvant -- methods
Female
Humans
Interferon-alpha -- therapeutic use
Male
Melanoma -- drug therapy -- mortality
Middle Aged
Neoplasm Staging
Polyethylene Glycols
Quality of Life
Recombinant Proteins
Skin Neoplasms -- drug therapy -- mortality
Note générale:Clinical Trial, Phase III
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2008.20.2069
info:pii/JCO.2008.20.2069
info:pmid/19433686